CompletedPhase 2NCT01402063
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
Studying Glioblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brown University
- Principal Investigator
- Howard Safran, MDBrUOG
- Intervention
- PPX (CT2103)(drug)
- Enrollment
- 63 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2015
Study locations (9)
- UCSD Cancer Center, La Jolla, California, United States
- Maine Medical Center, Scarborough, Maine, United States
- UMASS Medical Center Cancer Center, Worcester, Massachusetts, United States
- SUNY Medical Center, Syracuse, New York, United States
- PSU, Hershey, Pennsylvania, United States
- Thomas Jefferson University Cancer Center, Philadelphia, Pennsylvania, United States
- Rhode Island Hospital, Providence, Rhode Island, United States
- UT Southwestern Cancer Center, Dallas, Texas, United States
- University of Washington, Seattle, Washington, United States
Collaborators
Rhode Island Hospital · Milton S. Hershey Medical Center · University of Washington · University of Massachusetts, Worcester · MaineHealth · University of California, San Diego · Thomas Jefferson University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01402063 on ClinicalTrials.govOther trials for Glioblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07326566Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIBlack Diamond Therapeutics, Inc.
- RECRUITINGPHASE1, PHASE2NCT07501559A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)Jecho Biopharmaceuticals Co., Ltd.
- RECRUITINGPHASE1NCT07464925A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade GliomaTetragon Biosciences Ltd
- RECRUITINGNCT07411690Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial TumorsMedical University of Warsaw
- RECRUITINGPHASE1NCT07480941Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade GliomaBeijing Biotech
- RECRUITINGPHASE2NCT07225621Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed GlioblastomaAlpheus Medical, Inc.
- RECRUITINGPHASE1, PHASE2NCT073912155G-PEARL: Paxalisib in Malignant Brain TumoursInstitute of Cancer Research, United Kingdom
- RECRUITINGNANCT07426848OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour PatientsRoyal College of Surgeons, Ireland